bupropion hydrochloride (xl)
Generic: bupropion hydrochloride
Labeler: a-s medication solutionsDrug Facts
Product Profile
Brand Name
bupropion hydrochloride (xl)
Generic Name
bupropion hydrochloride
Labeler
a-s medication solutions
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
Active Ingredients
bupropion hydrochloride 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50090-7335
Product ID
50090-7335_0e701a91-3362-4074-b22d-7a1d2274afc3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207479
Listing Expiration
2026-12-31
Marketing Start
2017-04-12
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
500907335
Hyphenated Format
50090-7335
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bupropion hydrochloride (xl) (source: ndc)
Generic Name
bupropion hydrochloride (source: ndc)
Application Number
ANDA207479 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7335-0)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "0e701a91-3362-4074-b22d-7a1d2274afc3", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["0ac739de-ad59-4882-810e-f52db22ac96f"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-7335-0)", "package_ndc": "50090-7335-0", "marketing_start_date": "20241015"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "50090-7335_0e701a91-3362-4074-b22d-7a1d2274afc3", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-7335", "generic_name": "bupropion hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA207479", "marketing_category": "ANDA", "marketing_start_date": "20170412", "listing_expiration_date": "20261231"}